These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 38530512)
1. Expression of long non-coding RNA GAS5 by first trimester screening predicts the occurrence of gestational hypertension and pre-eclampsia. Wang L; Chen J; Li H; Zhou Q; Zhang C J Assist Reprod Genet; 2024 Jun; 41(6):1661-1667. PubMed ID: 38530512 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA myocardial infarction associated transcript expression and clinical significance in patients with hypertension during pregnancy. Wu X; Su R Ir J Med Sci; 2022 Oct; 191(5):2223-2228. PubMed ID: 34652723 [TBL] [Abstract][Full Text] [Related]
3. Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia. Huang T; Bedford HM; Rashid S; Rasasakaram E; Priston M; Mak-Tam E; Gibbons C; Meschino WS; Cuckle H; Mei-Dan E BMC Pregnancy Childbirth; 2022 Mar; 22(1):190. PubMed ID: 35260099 [TBL] [Abstract][Full Text] [Related]
4. Thromboelastography (TEG) in normal pregnancy and its diagnostic efficacy in patients with gestational hypertension, gestational diabetes mellitus, or preeclampsia. Xie X; Wang M; Lu Y; Zeng J; Wang J; Zhang C; Zhu H; Song Y; Han L; Liu Y; Zhang J; Li L; Chen L; Zhai Y; Cao Z J Clin Lab Anal; 2021 Feb; 35(2):e23623. PubMed ID: 33067885 [TBL] [Abstract][Full Text] [Related]
5. The Assessment of Copeptin and Brain Natriuretic Peptide Levels as Biomarkers in Hypertensive Disorders of Pregnancy. Okwor CJ; Adedapo KS; Bello OO; Adedapo AD; Okwor VC West Afr J Med; 2020; 37(3):231-236. PubMed ID: 32476116 [TBL] [Abstract][Full Text] [Related]
6. Assessment of the SFlt-1 and sFlt-1/25(OH)D Ratio as a Diagnostic Tool in Gestational Hypertension (GH), Preeclampsia (PE), and Gestational Diabetes Mellitus (GDM). Walentowicz-Sadlecka M; Domaracki P; Sadlecki P; Siodmiak J; Grabiec M; Walentowicz P; Moliz MTA; Odrowaz-Sypniewska G Dis Markers; 2019; 2019():5870239. PubMed ID: 31481983 [TBL] [Abstract][Full Text] [Related]
8. The Prediction of Gestational Hypertension, Preeclampsia and Fetal Growth Restriction via the First Trimester Screening of Plasma Exosomal C19MC microRNAs. Hromadnikova I; Dvorakova L; Kotlabova K; Krofta L Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216670 [TBL] [Abstract][Full Text] [Related]
9. Expression and clinical significance of lncRNA NORAD in patients with gestational hypertension. Liang Z; Wang L Ginekol Pol; 2023; 94(6):429-434. PubMed ID: 35894504 [TBL] [Abstract][Full Text] [Related]
10. Correlation of Maternal Serum Homocysteine in the First Trimester with the Development of Gestational Hypertension and Preeclampsia. Sun F; Qian W; Zhang C; Fan JX; Huang HF Med Sci Monit; 2017 Nov; 23():5396-5401. PubMed ID: 29129906 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic and Prognostic Value of Deregulated Long Non-Coding RNA Plasmacytoma Variant Translocation 1 in Patients with Gestational Hypertension. Xu T; Ma W; Gao J; Wang S Tohoku J Exp Med; 2022 Dec; 259(1):9-15. PubMed ID: 36047133 [TBL] [Abstract][Full Text] [Related]
12. First-trimester mean arterial blood pressure and the risk of preeclampsia: The Great Obstetrical Syndromes (GOS) study. Gasse C; Boutin A; Coté M; Chaillet N; Bujold E; Demers S Pregnancy Hypertens; 2018 Apr; 12():178-182. PubMed ID: 29175170 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia. Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758 [TBL] [Abstract][Full Text] [Related]
15. Early pregnancy screening for hypertensive disorders in women without a-priori high risk. Abdelaziz A; Maher MA; Sayyed TM; Bazeed MF; Mohamed NS Ultrasound Obstet Gynecol; 2012 Oct; 40(4):398-405. PubMed ID: 22689569 [TBL] [Abstract][Full Text] [Related]
16. Fetal fraction of cell free DNA in screening for hypertensive disorders at 11-13 weeks. Sapantzoglou I; Gallardo Arozena M; Dragoi V; Akolekar R; Nicolaides KH; Syngelaki A J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5363-5368. PubMed ID: 33517808 [TBL] [Abstract][Full Text] [Related]
17. Second trimester maternal serum D-dimer combined with alpha-fetoprotein and free β-subunit of human chorionic gonadotropin predict hypertensive disorders of pregnancy: a systematic review and retrospective case-control study. Chen Y; Chen Y; Wang X; Chu X; Ning W; Gu L; Li L; Xie Z; Wen C J Transl Med; 2021 Mar; 19(1):94. PubMed ID: 33653375 [TBL] [Abstract][Full Text] [Related]
18. A prediction model for the progression from gestational hypertension to pre-eclampsia complicated with HELLP syndrome. Li Z; Dai Y; Yun L; Guo W Int J Gynaecol Obstet; 2024 Jun; 165(3):1002-1012. PubMed ID: 38018274 [TBL] [Abstract][Full Text] [Related]
19. The first-trimester maternal serum cyclophilin A concentrations in women with complicated pregnancy as preeeclampsia. Wang ZH; Sun SY; Chen QN; Li YY; Cai XH Clin Chim Acta; 2018 Sep; 484():105-110. PubMed ID: 29842856 [TBL] [Abstract][Full Text] [Related]
20. Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-A or placental growth factor? Noël L; Guy GP; Jones S; Forenc K; Buck E; Papageorghiou AT; Thilaganathan B Ultrasound Obstet Gynecol; 2021 Oct; 58(4):540-545. PubMed ID: 33998078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]